The role of vaccines in combating antimicrobial resistance (AMR) bacteria

Most pathogens have developed an intrinsic capacity to thrive by developing resistance to antimicrobial compounds utilized in treatment. Antimicrobial resistance arises when microbial agents such as bacteria, viruses, fungi, and parasites alter their behaviour to make current conventional medicines...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Saad Alghamdi
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Antimicrobial resistance Antimicrobials Immunization Vaccine development Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/2616b1bddd5f4596872f8d16feffe82e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2616b1bddd5f4596872f8d16feffe82e
record_format	dspace
spelling	oai:doaj.org-article:2616b1bddd5f4596872f8d16feffe82e2021-11-20T04:57:12ZThe role of vaccines in combating antimicrobial resistance (AMR) bacteria1319-562X10.1016/j.sjbs.2021.08.054https://doaj.org/article/2616b1bddd5f4596872f8d16feffe82e2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1319562X21007439https://doaj.org/toc/1319-562XMost pathogens have developed an intrinsic capacity to thrive by developing resistance to antimicrobial compounds utilized in treatment. Antimicrobial resistance arises when microbial agents such as bacteria, viruses, fungi, and parasites alter their behaviour to make current conventional medicines inefficient. Vaccination is one of the most effective strategies to fight antimicrobial resistance. Vaccines, unlike drugs, are less likely to produce resistance since they are precise to their target illnesses. Vaccines against infectious agents such as Streptococcus pneumoniae and Haemophilus influenzae have already been shown to reduce tolerance to antimicrobial medications; however, vaccines against some antimicrobial-resistant pathogens such as Vibrio cholerae, Salmonella typhi, Escherichia coli, nosocomial infections, and pulmonary and diarrheal disease viruses require more research and development. This paper describes vaccine roles in combatting antimicrobial resistance, quantifies the overall advantages of vaccination as an anti-antimicrobial resistance approach, analyzes existing antimicrobial vaccines and those currently under development, and emphasizes some of the obstacles and prospects of vaccine research and development.Saad AlghamdiElsevierarticleAntimicrobial resistanceAntimicrobialsImmunizationVaccine developmentBiology (General)QH301-705.5ENSaudi Journal of Biological Sciences, Vol 28, Iss 12, Pp 7505-7510 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Antimicrobial resistance Antimicrobials Immunization Vaccine development Biology (General) QH301-705.5
spellingShingle	Antimicrobial resistance Antimicrobials Immunization Vaccine development Biology (General) QH301-705.5 Saad Alghamdi The role of vaccines in combating antimicrobial resistance (AMR) bacteria
description	Most pathogens have developed an intrinsic capacity to thrive by developing resistance to antimicrobial compounds utilized in treatment. Antimicrobial resistance arises when microbial agents such as bacteria, viruses, fungi, and parasites alter their behaviour to make current conventional medicines inefficient. Vaccination is one of the most effective strategies to fight antimicrobial resistance. Vaccines, unlike drugs, are less likely to produce resistance since they are precise to their target illnesses. Vaccines against infectious agents such as Streptococcus pneumoniae and Haemophilus influenzae have already been shown to reduce tolerance to antimicrobial medications; however, vaccines against some antimicrobial-resistant pathogens such as Vibrio cholerae, Salmonella typhi, Escherichia coli, nosocomial infections, and pulmonary and diarrheal disease viruses require more research and development. This paper describes vaccine roles in combatting antimicrobial resistance, quantifies the overall advantages of vaccination as an anti-antimicrobial resistance approach, analyzes existing antimicrobial vaccines and those currently under development, and emphasizes some of the obstacles and prospects of vaccine research and development.
format	article
author	Saad Alghamdi
author_facet	Saad Alghamdi
author_sort	Saad Alghamdi
title	The role of vaccines in combating antimicrobial resistance (AMR) bacteria
title_short	The role of vaccines in combating antimicrobial resistance (AMR) bacteria
title_full	The role of vaccines in combating antimicrobial resistance (AMR) bacteria
title_fullStr	The role of vaccines in combating antimicrobial resistance (AMR) bacteria
title_full_unstemmed	The role of vaccines in combating antimicrobial resistance (AMR) bacteria
title_sort	role of vaccines in combating antimicrobial resistance (amr) bacteria
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/2616b1bddd5f4596872f8d16feffe82e
work_keys_str_mv	AT saadalghamdi theroleofvaccinesincombatingantimicrobialresistanceamrbacteria AT saadalghamdi roleofvaccinesincombatingantimicrobialresistanceamrbacteria
_version_	1718419704464277504

The role of vaccines in combating antimicrobial resistance (AMR) bacteria

Ejemplares similares